| MR编号 | AT/H/1011/001 |
|---|
| 药品名称 | Cabazitaxel EVER Pharma 10 mg/ml concentrate for solution for infusion |
|---|
| 活性成分 | |
|---|
| 剂型 | Concentrate for solution for infusion |
|---|
| 上市许可持有人 | EVER Valinject GmbH
Oberburgau 3
4866 Unterach am Attersee, Austria |
|---|
| 参考成员国 - 产品名称 | Austria (AT) Cabazitaxel EVER Pharma 10 mg/ml Konzentrat zur Herstellung einer Infusionslösung |
|---|
| 互认成员国 - 产品名称 | - Greece (GR)
- Romania (RO)
- Germany (DE)
Cabazitaxel EVER Pharma 10 mg/ml Konzentrat zur Herstellung einer - Denmark (DK)
- Belgium (BE)
Cabazitaxel EVER Pharma 10 mg/ml concentraat voor oplossing voor infusie - Netherlands (NL)
Cabazitaxel EVER Pharma 10 mg/ml concentraat voor oplossing voor infusie - United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- France (FR)
- Spain (ES)
- Portugal (PT)
- Italy (IT)
- Sweden (SE)
- Norway (NO)
Cabazitaxel EVER Pharma - Finland (FI)
- Poland (PL)
- Hungary (HU)
- Slovakia (SK)
Cabazitaxel EVER Pharma 10 mg/ml koncentrát na infúzny roztok - Slovenia (SI)
Kabazitaksel EVER Pharma 10 mg/ml koncentrat za raztopino za infundiranje - Croatia (HR)
Kabazitaksel EVER Pharma 10 mg/ml koncentrat za otopinu za infuziju - Bulgaria (BG)
Cabazitaxel EVER Pharma - Czechia (CZ)
Cabazitaxel EVER Pharma 10 mg/ml koncentrát pro infuzní roztok
|
|---|
| 许可日期 | 2020/07/24 |
|---|
| 最近更新日期 | 2024/04/22 |
|---|
| 药物ATC编码 | | 申请类型 | - TypeLevel1：Known Active Substance
- TypeLevel2：Initial Application
- TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|